Aptyx Appoints David Price as Chief Executive Officer
Aptyx, a leading medical device contract development and manufacturing organization (CDMO), today announced the appointment of David Price as Chief Executive Officer, effective immediately.
Aptyx, a leading medical device contract development and manufacturing organization (CDMO), today announced the appointment of David Price as Chief Executive Officer, effective immediately.
Located in the Boston medtech corridor and powered by the acquisition of Argos, the center delivers immediate expansion in extrusion technology and capacity to better support medtech innovation.
Aptyx will also host a booth at DeviceTalks Boston April 30 to May 1 and serve as legacy sponsor of "Women in Medtech Breakfast."
The acquisition amplifies interventional expertise and launches Aptyx Interventional Systems
Molded Devices Inc. (MDI) rebrands as Aptyx. The new brand brings together the aptitude and excellence of more than a dozen companies with 70+ years in complex manufacturing.